Apollo Hospitals (APOLLOHOSP) Stock Price, Fundamentals & Analysis

What APOLLOHOSP does

Apollo Hospitals (APOLLOHOSP) is a healthcare stock listed on the National Stock Exchange of India. It operates hospitals and clinics offering primary, secondary, and tertiary care, along with specialty services in areas such as cardiac sciences, oncology, neurosciences, orthopedics, and organ transplantation. The company also runs retail health and diagnostics, digital health and pharmacy distribution, medical education through Medvarsity, and acts as an agent for life, general, and health insurance. Within the Indian healthcare space, it is a peer of companies like Max Healthcare (MAXHEALTH), Cipla (CIPLA), Dr. Reddy's Laboratories (DRREDDY), and Sun Pharma (SUNPHARMA), and it can be compared internationally with firms such as Novartis International AG (NOVN), EssilorLuxottica (EL), and CSL (CSL).

Key numbers explained

• Price: The current trading price is 8,889 INR per share.
• Trailing P/E ratio: 61.3 — this shows how much investors pay per rupee of the company's last 12 months' earnings; a higher number often reflects expectations of future growth.
• Forward P/E ratio: 40.8 — similar to the trailing P/E but based on expected future earnings, which can make the stock look less expensive if growth is anticipated.
• Dividend yield: 0.22% — the annual dividend payment as a percentage of the current share price, indicating a modest income return.
• Ex-dividend date: Aug 14, 2026 — the date by which you must own the stock to receive the next dividend payment.
• Beta: 0.2 — a measure of volatility relative to the market; a beta below 1 suggests the stock tends to move less than the broader market.
• 52-week range: 6,696.5 – 9,070.5 INR — the lowest and highest prices over the past year, showing the recent trading band.
• Revenue growth, year over year: 20.6% — the rate at which the company's top line has grown over the last 12 months.
• Debt-to-equity ratio: 85.1% — the proportion of debt used relative to shareholders' equity, indicating the company's financial leverage.

What to watch

• The healthcare sector can be sensitive to government policy, regulation, and public health spending in India.
• A high trailing P/E ratio like 61.3 may reflect growth expectations; if earnings growth slows, the valuation could be reassessed.
• The dividend yield of 0.22% is low, so income-focused investors may look elsewhere, while the ex-dividend date of Aug 14, 2026 sets the key calendar point for the next payout.
• The debt-to-equity ratio of 85.1% is a factor to monitor, as it shows the company uses a meaningful amount of debt relative to equity.
• Revenue growth of 20.6% and a profitMargin of 7.9% together show how efficiently the company converts sales into profit.
• As a large-cap stock with a 1.28T INR marketCap, APOLLOHOSP is part of the broader National Stock Exchange of India stocks universe and can be tracked alongside peers in the Stocks directory.